NGF Blog

Ambroxol, a glucocerebrosidase (GCase) activator, represents a potential new treatment for the most severe neurological symptoms of Gaucher disease.
Blog / About Gaucher Disease

Ambroxol: New Use as a Gaucher Disease Treatment?

Research on the medication Ambroxol and other existing drugs with... Read more

Cannabis for Gaucher disease pain
Blog / About Gaucher Disease

Cannabis for Gaucher Disease Pain

Chronic joint pain is a common symptom of Gaucher disease.... Read more

Hands holding a drawing of a fetus
Blog / About Gaucher Disease

Ashkenazi Jewish Prenatal Genetic Screening: What Future Parents Should Know

People of Ashkenazi Jewish descent have a higher risk of... Read more

Research on small molecule therapy a potential treatment for Gaucher disease
Blog / About Gaucher Disease

Small Molecule Therapy for Gaucher Disease and GBA1-Associated Parkinson’s Disease

Mutations of the GBA gene cause Gaucher disease and are... Read more

Patient receiving therapy for Gaucher disease.
Blog / About Gaucher Disease

Enzyme Replacement Therapy for Gaucher Disease: Frequently Asked Questions

People with Gaucher disease, an inherited condition, don’t make enough... Read more

A fetal therapy for Gaucher disease clinical trial offers new hope for expecting couples
Blog / About Gaucher Disease

Fetal Therapy for Gaucher Disease

Gaucher disease causes glucocerebroside to build up in cells, which... Read more

Blog / About the National Gaucher Foundation

NGF Global Diagnostic and Treatment Initiative Heads to India

Dr. Robin A. Ely, Clinical/Science Advisor, Director of the National... Read more

Blog / Patient Journeys

Gaucher Journey: Shauna Mangum

Want to share your story? Contact us and we’ll be... Read more

News

National Gaucher Foundation Founder Robin Ely, MD to Speak in India

As part of organization’s Global Diagnostic and Treatment Initiative, Dr.... Read more

Blog / Patient Journeys

Gaucher Journey: Betsy Findley

Want to share your story? Contact us and we’ll be... Read more

Living a Better Today

Skip to content